Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (81-90 of 183) with videos related to

Pageof 19
Sort By:
Blood|July 1, 1996
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myelomaD Billadeau, B Van Ness, T Kimlinger, et al.
Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphomaM Gupta, M Stenson, M O'Byrne, et al.
British Journal of Haematology|June 3, 1998
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 casesR Fonseca, T E Witzig, M A Gertz, et al.
American Journal of Hematology|April 1, 1985
Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhageT E Witzig, B S Ducatman, M R Wick, et al.
Leukemia & Lymphoma|September 24, 1999
Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International IndexS M Ansell, P J Kurtin, M Stenson, et al.
Archives of Internal Medicine|October 23, 1995
Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trialJ P Garton, M A Gertz, T E Witzig, et al.
The New England Journal of Medicine|April 24, 1997
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicineR A Kyle, M A Gertz, P R Greipp, et al.
Neurology|January 1, 1991
Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literatureD H Lachance, B P O'Neill, D R Macdonald, et al.
British Journal of Haematology|May 3, 2000
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucilR A Kyle, P R Greipp, M A Gertz, et al.
Pageof 19

Showing results (81-90 of 183) with videos related to

Sort By:
Pageof 19
Blood|July 1, 1996
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myelomaD Billadeau, B Van Ness, T Kimlinger, et al.
Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphomaM Gupta, M Stenson, M O'Byrne, et al.
British Journal of Haematology|June 3, 1998
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 casesR Fonseca, T E Witzig, M A Gertz, et al.
American Journal of Hematology|April 1, 1985
Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhageT E Witzig, B S Ducatman, M R Wick, et al.
Leukemia & Lymphoma|September 24, 1999
Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International IndexS M Ansell, P J Kurtin, M Stenson, et al.
Archives of Internal Medicine|October 23, 1995
Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trialJ P Garton, M A Gertz, T E Witzig, et al.
The New England Journal of Medicine|April 24, 1997
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicineR A Kyle, M A Gertz, P R Greipp, et al.
Neurology|January 1, 1991
Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literatureD H Lachance, B P O'Neill, D R Macdonald, et al.
British Journal of Haematology|May 3, 2000
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucilR A Kyle, P R Greipp, M A Gertz, et al.
Pageof 19